CIS Bio International

Address: Sarclay, Gif Sur Yvette Cedex 91192, France
Phone: +33-(169)-857070 | Fax: +33-(169)-857071 | Map/Directions >>

Profile: CIS Bio International is engaged in the field of biomedical technology. We specialize in biomedical technology, particularly in the radioactive labeling of molecules. Our products are used in nuclear medicine therapy & imaging, medical diagnostics and in vitro screening of molecules. We also develop radioactive elements for medical purposes. We offer innovative products on the market, in specialties such as oncology, endocrinology, cardiology, pulmonary disorders, neurology and rheumatology.

13 Products/Services (Click for related suppliers)

• ACTH Radioimmunoassay Test (FDA Code: CKG / 862.1025)

An adrenocorticotropic hormone (ACTH) test system is a device intended to measure adrenocorticotropic hormone in plasma and serum. ACTH measurements are used in the differential diagnosis and treatment of certain disorders of the adrenal glands such as Cushing's syndrome, adrenocortical insufficiency, and the ectopic ACTH syndrome.

• Angiotensin I and Renin Radioimmunoassay Test (FDA Code: CIB / 862.1085)

An angiotensin I and renin test system is a device intended to measure the level of angiotensin I generated by renin in plasma. Angiotensin I measurements are used in the diagnosis and treatment of certain types of hypertension.

• Ferritin Radioimmunoassay Test (FDA Code: JMG / 866.5340)

A ferritin immunological test system is a device that consists of the reagents used to measure by immunochemical techniques the ferritin (an iron-storing protein) in serum and other body fluids. Measurements of ferritin aid in the diagnosis of diseases affecting iron metabolism, such as hemochromatosis (iron overload) and iron deficiency amemia.

• Follicle Stimulating Hormone Radioimmunoassay (FDA Code: CGJ / 862.1300)

A follicle-stimulating hormone test system is a device intended to measure follicle-stimulating hormone (FSH) in plasma, serum, and urine. FSH measurements are used in the diagnosis and treatment of pituitary gland and gonadal disorders.

• Gastrin Radioimmunoassay Test (FDA Code: CGC / 862.1325)

A gastrin test system is a device intended to measure the hormone gastrin in plasma and serum. Measurements of gastrin are used in the diagnosis and treatment of patients with ulcers, pernicious anemia, and the Zollinger-Ellison syndrome (peptic ulcer due to a gastrin-secreting tumor of the pancreas).

• Human Placental Lactogen Radioimmunoassay (FDA Code: JMF / 862.1585)

A human placental lactogen test system is a device intended to measure the hormone human placental lactogen (HPL), (also known as human chorionic somatomammotrophin (HCS)), in maternal serum and maternal plasma. Measurements of human placental lactogen are used in the diagnosis and clinical management of high-risk pregnancies involving fetal distress associated with placental insufficiency. Measurements of HPL are also used in pregnancies complicated by hypertension, proteinuria, edema, post-maturity, placental insufficiency, or possible miscarriage.

• Luteinizing Hormone Radioimmunoassay (FDA Code: CEP / 862.1485)

A luteinizing hormone test system is a device intended to measure luteinizing hormone in serum and urine. Luteinizing hormone measurements are used in the diagnosis and treatment of gonadal dysfunction.

• Nuclear Flood Source Phantom (FDA Code: IYQ / 892.1380)

A nuclear flood source phantom is a device that consists of a radiolucent container filled with a uniformly distributed solution of a desired radionuclide. It is intended to calibrate a medical gamma camera-collimator system for uniformity of response.

• Nuclear Sealed Calibration Source (FDA Code: IXD / 892.1400)

A nuclear sealed calibration source is a device that consists of an encapsulated reference radionuclide intended for calibration of medical nuclear radiation detectors.

• Radionuclide Rebreathing System (FDA Code: IYT / 892.1390)

A radionuclide rebreathing system is a device intended to be used to contain a gaseous or volatile radionuclide or a radionuclide-labeled aerosol and permit it to be respired by the patient during nuclear medicine ventilatory tests (testing process of exchange between the lungs and the atmosphere). This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.

• Thyroid Stimulating Hormone Radioimmunoassay (FDA Code: JLW / 862.1690)

A thyroid stimulating hormone test system is a device intended to measure thyroid stimulating hormone, also known as thyrotrophin and thyrotrophic hormone, in serum and plasma. Measurements of thyroid stimulating hormone produced by the anterior pituitary are used in the diagnosis of thyroid or pituitary disorders.

• Thyroxine Binding Globulin Radioimmunoassay (FDA Code: CEE / 862.1685)

A thyroxine-binding globulin test system is a device intended to measure thyroxine (thyroid)-binding globulin (TBG), a plasma protein which binds thyroxine, in serum and plasma. Measurements obtained by this device are used in the diagnosis and treatment of thyroid diseases.

• Total Thyroxine Radioimmunoassay (FDA Code: CDX / 862.1700)

A total thyroxine test system is a device intended to measure total (free and protein bound) thyroxine (thyroid hormone) in serum and plasma. Measurements obtained by this device are used in the diagnosis and treatment of thyroid diseases.